About Beeline Medicines
Let’s get to what matters. To life lived fully.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Stamford, Connecticut
- Founded
- 2025
- Company type
- Privately Held
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases.
We are here to chart a new path for patients, rigorously pushing the science forward to deliver therapies that go straight to the drivers of immune dysfunction to define new treatment paradigms. Our portfolio is comprised of therapeutic candidates rooted in validated biology, powered by best-in-class molecular properties, and driven by an efficient clinical development strategy designed for differentiated, lasting impact for patients.
Grounded in scientific rigor and driven by purpose, we get to what matters so that people living with immune-mediated diseases can live life fully.
Specialties
- Biotechnology
- pharmaceuticals
- drug development
- clinical development
- inflammatory diseases
- autoimmune diseases
- immune-mediated diseases
- immunology
- and precision therapies
Company locations
Stamford, Connecticut, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Biotechnology
- Health Care
- Therapeutics
On LinkedIn
- Followers
- 4,406
- People linked to this company
- 57
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
426,300,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.